In contrast, down-regulation of 14-3-3 expression sensitizes cancer cells to chemotherapeutic drugs [2], [20], including prostate cancer [21], implicating the therapeutic potential of 14-3-3ζ for cancer therapy. The gene discussed is YWHAQ; the disease is prostate cancer.